Geron Corporation (United States)

Geron Corporation is a clinical-stage biopharmaceutical company developing cancer therapies targeting telomerase. Based in Foster City, California, Geron developed imetelstat, a first-in-class telomerase inhibitor for myelodysplastic syndromes (MDS) and myelofibrosis. The company’s research focuses on hematological malignancies where telomerase plays a critical role in cancer cell survival.